Exploring Risvidetinib in Phase 2 Trial for Untreated Parkinson Disease
Published October 9, 2025
An interview with Matt Hoffman of NeurologyLive, conducted following the Clinical Breakthrough Keynote lecture I gave at the International Movement Disorders Congress in Honolulu, HI on October 9, 2025.
Published October 9, 2025